Lazzarin A - Search Results

1

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.

Nozza S, Bigoloni A, Calcagno A, Galli L, Pignataro AR, D'Avolio A, Carbone A, Ripa M, Bonora S, Lazzarin A, Castagna A. Nozza S, et al. Among authors: lazzarin a. J Antimicrob Chemother. 2014 May;69(5):1436-9. doi: 10.1093/jac/dkt530. Epub 2014 Jan 23. J Antimicrob Chemother. 2014. PMID: 24458511 No abstract available.

2

Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.

Fortis C, Soldini L, Ghezzi S, Colombo S, Tambussi G, Vicenzi E, Gianotti N, Nozza S, Veglia F, Murone M, Lazzarin A, Poli G. Fortis C, et al. Among authors: lazzarin a. AIDS Res Hum Retroviruses. 2002 May 1;18(7):491-9. doi: 10.1089/088922202317406637. AIDS Res Hum Retroviruses. 2002. PMID: 12015902 Clinical Trial.

3

Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.

Malnati M, Broccolo F, Nozza S, Sarmati L, Ghezzi S, Locatelli G, Delfanti F, Capiluppi B, Careddu A, Andreoni M, Monini P, Poli G, Lazzarin A, Lusso P, Tambussi G. Malnati M, et al. Among authors: lazzarin a. Blood. 2002 Sep 1;100(5):1575-8. Blood. 2002. PMID: 12176873 Free article.

4

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.

Uberti-Foppa C, De Bona A, Morsica G, Galli L, Gallotta G, Boeri E, Lazzarin A. Uberti-Foppa C, et al. Among authors: lazzarin a. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52. doi: 10.1097/00126334-200306010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12794546 Clinical Trial.

5

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.

Porcellini S, Vallanti G, Nozza S, Poli G, Lazzarin A, Tambussi G, Siccardi AG, Grassi F. Porcellini S, et al. Among authors: lazzarin a. AIDS. 2003 Jul 25;17(11):1621-30. doi: 10.1097/00002030-200307250-00006. AIDS. 2003. PMID: 12853744 Clinical Trial.

6

Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.

Brambilla AM, Novati R, Calori G, Meneghini E, Vacchini D, Luzi L, Castagna A, Lazzarin A. Brambilla AM, et al. Among authors: lazzarin a. AIDS. 2003 Sep 5;17(13):1993-5. doi: 10.1097/00002030-200309050-00022. AIDS. 2003. PMID: 12960836

7

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.

Tasca S, Tambussi G, Nozza S, Capiluppi B, Zocchi MR, Soldini L, Veglia F, Poli G, Lazzarin A, Fortis C. Tasca S, et al. Among authors: lazzarin a. AIDS. 2003 Nov 7;17(16):2291-8. doi: 10.1097/00002030-200311070-00003. AIDS. 2003. PMID: 14571180

8

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.

Guffanti M, De Pascalis CR, Seminari E, Fusetti G, Gianotti N, Bassetti D, Galli A, Castagna A, Lazzarin A. Guffanti M, et al. Among authors: lazzarin a. AIDS. 2003 Dec 5;17(18):2669-71. doi: 10.1097/00002030-200312050-00017. AIDS. 2003. PMID: 14685066

9

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.

Gianotti N, Soria A, Galli L, Castagna A, Cernuschi M, Hasson H, Lazzarin A. Gianotti N, et al. Among authors: lazzarin a. J Med Virol. 2004 Feb;72(2):181-6. doi: 10.1002/jmv.10580. J Med Virol. 2004. PMID: 14695657

10

Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.

Boeri E, Gianotti N, Canducci F, Hasson H, Giudici B, Castagna A, Lazzarin A, Clementi M. Boeri E, et al. Among authors: lazzarin a. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1151-3. doi: 10.1089/088922203771881257. AIDS Res Hum Retroviruses. 2003. PMID: 14714567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

885 results

Search Page

Filters